Status:
COMPLETED
Antibiotics for the Treatment of Ulcerative Colitis
Lead Sponsor:
University of Dundee
Collaborating Sponsors:
Tenovus Scotland
Conditions:
Colitis, Ulcerative
Eligibility:
All Genders
18-79 years
Phase:
NA
Brief Summary
Ulcerative colitis (UC) is an acute and chronic inflammatory bowel disease, whose cause is unknown. However, it is widely accepted that bacteria living in the large bowel are essential for the develop...
Detailed Description
It is now widely acknowledged, as a result of experimental studies over the last 30 years, that the mucosal flora of the large bowel are essential to the pathogenesis of ulcerative colitis. Whilst tre...
Eligibility Criteria
Inclusion
- Active ulcerative colitis, CAI greater than or equal to 4
Exclusion
- Antibiotics in the last 3 months
- Probiotics
- Alteration to medications in last 3 months
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00355602
Start Date
July 1 2006
End Date
December 1 2008
Last Update
February 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ninewells Hospital and Medical School
Dundee, Angus, United Kingdom, DD1 9SY